Perdurable PD-1 blockage awakes anti-tumor immunity suppressed by precise chemotherapy

被引：0

作者：

Jiang, Mengshi ^{[1
]}

Li, Wei ^{[2
]}

Zhu, Chunqi ^{[1
]}

Li, Xiang ^{[1
]}

Zhang, Junlei ^{[1
]}

Luo, Zhenyu ^{[1
]}

Qin, Bing ^{[1
]}

Du, Yongzhong ^{[1
]}

Luo, Lihua ^{[1
]}

You, Jian ^{[1
]}

机构：

[1] College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou,Zhejiang,310058, China

[2] Department of Pharmacology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas,TX,75390, United States

来源：

Journal of Controlled Release | 2021年 / 329卷

基金：

中国国家自然科学基金;

关键词：

Targeted drug delivery - Hyaluronic acid - Cancer cells - Cytology - Micelles - Diseases - Drug interactions - Tumors - Controlled drug delivery - Covalent bonds - Immune system - Pathology - Sulfur compounds - Drug dosage - Cells;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1023 / 1036

共 50 条

[1] Perdurable PD-1 blockage awakes anti-tumor immunity suppressed by precise chemotherapy
Jiang, Mengshi
Li, Wei
Zhu, Chunqi
Li, Xiang
Zhang, Junlei
Luo, Zhenyu
Qin, Bing
Du, Yongzhong
Luo, Lihua
You, Jian
JOURNAL OF CONTROLLED RELEASE, 2021, 329 : 1023 - 1036
[2] PD-1 blockade: promoting endogenous anti-tumor immunity
Peggs, Karl S.
Quezada, Sergio A.
EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1279 - 1282
[3] Targeting glycosylated PD-1 induces potent anti-tumor immunity
Wang, Yuhan
Sun, Linlin
Yang, Riyao
Liu, Jielin
Qiu, Yufan
Hsu, Jennifer L.
Cha, Jong-ho
Chan, Li-Chuan
Hsu, Jung-Mao
Lee, Heng-Huan
Lai, Yun-Ju
Khoo, Kay-Hooi
Chung, Ezra M.
Li, Chia-Wei
Kim, Yong-Soo
Park, Andrew H.
Yang, Yi
Yoo, Stephen S.
Hung, Mien-Chie
CANCER RESEARCH, 2020, 80 (16)
[4] MicroRNA-29a synergizes with PD-1 therapy to regulate anti-tumor immunity
Leng, Xuebing
Ristin, Svetlana
Rafie, Christine
Buchness, Lance
Villarino, Alejandro
Stelekati, Erietta
CANCER RESEARCH, 2023, 83 (07)
[5] Sintilimab: A Promising Anti-Tumor PD-1 Antibody
Zhang, Lin
Mai, Wuqian
Jiang, Wenyang
Geng, Qing
FRONTIERS IN ONCOLOGY, 2020, 10
[6] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
Li, Baoqi
Fang, Tianliang
Li, Yuan
Xue, Tianyuan
Zhang, Zhirang
Li, Liyan
Meng, Fanqiang
Wang, Jinqiang
Hou, Linlin
Liang, Xin
Zhang, Xudong
Gu, Zhen
NANO TODAY, 2022, 46
[7] SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
Zhao, M.
Guo, W.
Xu, Q.
Sun, Y.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1856 - 1856
[8] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
Li, Baoqi
Fang, Tianliang
Li, Yuan
Xue, Tianyuan
Zhang, Zhirang
Li, Liyan
Meng, Fanqiang
Wang, Jinqiang
Hou, Linlin
Liang, Xin
Zhang, Xudong
Gu, Zhen
Nano Today, 2022, 46
[9] SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
Zhao, Mingxia
Guo, Wenjie
Wu, Yuanyuan
Yang, Chenxi
Zhong, Liang
Deng, Guoliang
Zhu, Yuyu
Liu, Wen
Gu, Yanhong
Lu, Yin
Kong, Lingdong
Meng, Xiangbao
Xu, Qiang
Sun, Yang
ACTA PHARMACEUTICA SINICA B, 2019, 9 (02) : 304 - 315
[10] SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
Mingxia Zhao
Wenjie Guo
Yuanyuan Wu
Chenxi Yang
Liang Zhong
Guoliang Deng
Yuyu Zhu
Wen Liu
Yanhong Gu
Yin Lu
Lingdong Kong
Xiangbao Meng
Qiang Xu
Yang Sun
ActaPharmaceuticaSinicaB, 2019, 9 (02) : 304 - 315

← 1 2 3 4 5 →